Quantification of the Brain Proteome in Alzheimer’s Disease Using Multiplexed Mass Spectrometry
Sravani Musunuri(Uppsala University), Ganna Shevchenko(Uppsala University), Konstantin A. Artemenko(Uppsala University), Jonas Bergquist(Uppsala University), Kim Kultima(Uppsala University), Martin Ingelsson(Uppsala University), Magnus Wetterhall(Uppsala University), Lars Lannfelt(BioArctic Neuroscience (Sweden))
Cited by 101
Related Papers
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
|Neurology|2004|655
High levels of AAV vector integration into CRISPR-induced DNA breaks
|Nature Communications|2019|430